- IBDEI0CW ; ; 03-MAY-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,32356,1,4,0)
- ;;=4^L20.89
- ;;^UTILITY(U,$J,358.3,32356,2)
- ;;=^5009112
- ;;^UTILITY(U,$J,358.3,32357,0)
- ;;=L25.9^^97^1335^15
- ;;^UTILITY(U,$J,358.3,32357,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32357,1,3,0)
- ;;=3^Contact Dermatitis,Unspec
- ;;^UTILITY(U,$J,358.3,32357,1,4,0)
- ;;=4^L25.9
- ;;^UTILITY(U,$J,358.3,32357,2)
- ;;=^5133647
- ;;^UTILITY(U,$J,358.3,32358,0)
- ;;=L40.0^^97^1335^16
- ;;^UTILITY(U,$J,358.3,32358,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32358,1,3,0)
- ;;=3^Psoriasis
- ;;^UTILITY(U,$J,358.3,32358,1,4,0)
- ;;=4^L40.0
- ;;^UTILITY(U,$J,358.3,32358,2)
- ;;=^5009160
- ;;^UTILITY(U,$J,358.3,32359,0)
- ;;=L29.9^^97^1335^17
- ;;^UTILITY(U,$J,358.3,32359,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32359,1,3,0)
- ;;=3^Pruritus
- ;;^UTILITY(U,$J,358.3,32359,1,4,0)
- ;;=4^L29.9
- ;;^UTILITY(U,$J,358.3,32359,2)
- ;;=^5009153
- ;;^UTILITY(U,$J,358.3,32360,0)
- ;;=L85.3^^97^1335^18
- ;;^UTILITY(U,$J,358.3,32360,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32360,1,3,0)
- ;;=3^Xerosis
- ;;^UTILITY(U,$J,358.3,32360,1,4,0)
- ;;=4^L85.3
- ;;^UTILITY(U,$J,358.3,32360,2)
- ;;=^5009323
- ;;^UTILITY(U,$J,358.3,32361,0)
- ;;=L30.2^^97^1335^19
- ;;^UTILITY(U,$J,358.3,32361,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32361,1,3,0)
- ;;=3^Cutaneous Autosensitization/ld
- ;;^UTILITY(U,$J,358.3,32361,1,4,0)
- ;;=4^L30.2
- ;;^UTILITY(U,$J,358.3,32361,2)
- ;;=^5009155
- ;;^UTILITY(U,$J,358.3,32362,0)
- ;;=L72.0^^97^1335^20
- ;;^UTILITY(U,$J,358.3,32362,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32362,1,3,0)
- ;;=3^Epidermal Cyst
- ;;^UTILITY(U,$J,358.3,32362,1,4,0)
- ;;=4^L72.0
- ;;^UTILITY(U,$J,358.3,32362,2)
- ;;=^5009277
- ;;^UTILITY(U,$J,358.3,32363,0)
- ;;=L73.9^^97^1335^21
- ;;^UTILITY(U,$J,358.3,32363,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32363,1,3,0)
- ;;=3^Follicular Disorder/Folliculitis
- ;;^UTILITY(U,$J,358.3,32363,1,4,0)
- ;;=4^L73.9
- ;;^UTILITY(U,$J,358.3,32363,2)
- ;;=^5009286
- ;;^UTILITY(U,$J,358.3,32364,0)
- ;;=L70.0^^97^1335^22
- ;;^UTILITY(U,$J,358.3,32364,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32364,1,3,0)
- ;;=3^Acne
- ;;^UTILITY(U,$J,358.3,32364,1,4,0)
- ;;=4^L70.0
- ;;^UTILITY(U,$J,358.3,32364,2)
- ;;=^5009268
- ;;^UTILITY(U,$J,358.3,32365,0)
- ;;=L71.8^^97^1335^23
- ;;^UTILITY(U,$J,358.3,32365,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32365,1,3,0)
- ;;=3^Rosacea
- ;;^UTILITY(U,$J,358.3,32365,1,4,0)
- ;;=4^L71.8
- ;;^UTILITY(U,$J,358.3,32365,2)
- ;;=^5009275
- ;;^UTILITY(U,$J,358.3,32366,0)
- ;;=L91.0^^97^1335^24
- ;;^UTILITY(U,$J,358.3,32366,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32366,1,3,0)
- ;;=3^Hypertrophic Scar
- ;;^UTILITY(U,$J,358.3,32366,1,4,0)
- ;;=4^L91.0
- ;;^UTILITY(U,$J,358.3,32366,2)
- ;;=^5009459
- ;;^UTILITY(U,$J,358.3,32367,0)
- ;;=L91.8^^97^1335^25
- ;;^UTILITY(U,$J,358.3,32367,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32367,1,3,0)
- ;;=3^Skin Tag/Oth Hypertrophic Disorder of Skin
- ;;^UTILITY(U,$J,358.3,32367,1,4,0)
- ;;=4^L91.8
- ;;^UTILITY(U,$J,358.3,32367,2)
- ;;=^5009460
- ;;^UTILITY(U,$J,358.3,32368,0)
- ;;=I87.2^^97^1335^26
- ;;^UTILITY(U,$J,358.3,32368,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32368,1,3,0)
- ;;=3^Stasis Dermatitis/Venous Insufficiency
- ;;^UTILITY(U,$J,358.3,32368,1,4,0)
- ;;=4^I87.2
- ;;^UTILITY(U,$J,358.3,32368,2)
- ;;=^5008047
- ;;^UTILITY(U,$J,358.3,32369,0)
- ;;=D69.8^^97^1335^27
- ;;^UTILITY(U,$J,358.3,32369,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32369,1,3,0)
- ;;=3^Purpura,Hemorrhagic Condition
- ;;^UTILITY(U,$J,358.3,32369,1,4,0)
- ;;=4^D69.8
- ;;^UTILITY(U,$J,358.3,32369,2)
- ;;=^88074
- ;;^UTILITY(U,$J,358.3,32370,0)
- ;;=L08.9^^97^1335^28
- ;;^UTILITY(U,$J,358.3,32370,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32370,1,3,0)
- ;;=3^Pyoderma
- ;;^UTILITY(U,$J,358.3,32370,1,4,0)
- ;;=4^L08.9
- ;;^UTILITY(U,$J,358.3,32370,2)
- ;;=^5009082
- ;;^UTILITY(U,$J,358.3,32371,0)
- ;;=L01.00^^97^1335^29
- ;;^UTILITY(U,$J,358.3,32371,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32371,1,3,0)
- ;;=3^Impetigo
- ;;^UTILITY(U,$J,358.3,32371,1,4,0)
- ;;=4^L01.00
- ;;^UTILITY(U,$J,358.3,32371,2)
- ;;=^5008938
- ;;^UTILITY(U,$J,358.3,32372,0)
- ;;=L03.90^^97^1335^30
- ;;^UTILITY(U,$J,358.3,32372,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32372,1,3,0)
- ;;=3^Cellulitis
- ;;^UTILITY(U,$J,358.3,32372,1,4,0)
- ;;=4^L03.90
- ;;^UTILITY(U,$J,358.3,32372,2)
- ;;=^5009067
- ;;^UTILITY(U,$J,358.3,32373,0)
- ;;=Z79.1^^97^1335^31
- ;;^UTILITY(U,$J,358.3,32373,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32373,1,3,0)
- ;;=3^Long Term Use NSAID/Oth Health Status
- ;;^UTILITY(U,$J,358.3,32373,1,4,0)
- ;;=4^Z79.1
- ;;^UTILITY(U,$J,358.3,32373,2)
- ;;=^5063332
- ;;^UTILITY(U,$J,358.3,32374,0)
- ;;=Z79.899^^97^1335^32
- ;;^UTILITY(U,$J,358.3,32374,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32374,1,3,0)
- ;;=3^Long Term Use Oth Drug
- ;;^UTILITY(U,$J,358.3,32374,1,4,0)
- ;;=4^Z79.899
- ;;^UTILITY(U,$J,358.3,32374,2)
- ;;=^5063343
- ;;^UTILITY(U,$J,358.3,32375,0)
- ;;=Z80.8^^97^1335^33
- ;;^UTILITY(U,$J,358.3,32375,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32375,1,3,0)
- ;;=3^Family Hx of Melanoma
- ;;^UTILITY(U,$J,358.3,32375,1,4,0)
- ;;=4^Z80.8
- ;;^UTILITY(U,$J,358.3,32375,2)
- ;;=^5063356
- ;;^UTILITY(U,$J,358.3,32376,0)
- ;;=Z48.817^^97^1335^34
- ;;^UTILITY(U,$J,358.3,32376,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32376,1,3,0)
- ;;=3^Surgical Aftercare Skin/Subcutaneous Tissue
- ;;^UTILITY(U,$J,358.3,32376,1,4,0)
- ;;=4^Z48.817
- ;;^UTILITY(U,$J,358.3,32376,2)
- ;;=^5063054
- ;;^UTILITY(U,$J,358.3,32377,0)
- ;;=R99.^^97^1335^35
- ;;^UTILITY(U,$J,358.3,32377,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32377,1,3,0)
- ;;=3^Dead Unknown Mortality
- ;;^UTILITY(U,$J,358.3,32377,1,4,0)
- ;;=4^R99.
- ;;^UTILITY(U,$J,358.3,32377,2)
- ;;=^5019750
- ;;^UTILITY(U,$J,358.3,32378,0)
- ;;=Z85.9^^97^1335^36
- ;;^UTILITY(U,$J,358.3,32378,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32378,1,3,0)
- ;;=3^Personal Hx of Unspec Neoplasm/Cancer
- ;;^UTILITY(U,$J,358.3,32378,1,4,0)
- ;;=4^Z85.9
- ;;^UTILITY(U,$J,358.3,32378,2)
- ;;=^5063452
- ;;^UTILITY(U,$J,358.3,32379,0)
- ;;=C79.9^^97^1335^37
- ;;^UTILITY(U,$J,358.3,32379,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32379,1,3,0)
- ;;=3^Metastatic Cancer Unspec
- ;;^UTILITY(U,$J,358.3,32379,1,4,0)
- ;;=4^C79.9
- ;;^UTILITY(U,$J,358.3,32379,2)
- ;;=^5133344
- ;;^UTILITY(U,$J,358.3,32380,0)
- ;;=Q3014^^98^1336^1^^^^1
- ;;^UTILITY(U,$J,358.3,32380,1,0)
- ;;=^358.31IA^3^2
- ;;^UTILITY(U,$J,358.3,32380,1,2,0)
- ;;=2^Q3014
- ;;^UTILITY(U,$J,358.3,32380,1,3,0)
- ;;=3^Telehealth Fac Fee-Pt Site
- ;;^UTILITY(U,$J,358.3,32381,0)
- ;;=B19.10^^99^1337^1
- ;;^UTILITY(U,$J,358.3,32381,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32381,1,3,0)
- ;;=3^Hepatitis B w/o Hepatic Coma
- ;;^UTILITY(U,$J,358.3,32381,1,4,0)
- ;;=4^B19.10
- ;;^UTILITY(U,$J,358.3,32381,2)
- ;;=^5000552
- ;;^UTILITY(U,$J,358.3,32382,0)
- ;;=B17.10^^99^1337^2
- ;;^UTILITY(U,$J,358.3,32382,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32382,1,3,0)
- ;;=3^Hepatitis C w/o Hepatic Coma,Acute
- ;;^UTILITY(U,$J,358.3,32382,1,4,0)
- ;;=4^B17.10
- ;;^UTILITY(U,$J,358.3,32382,2)
- ;;=^5000542
- ;;^UTILITY(U,$J,358.3,32383,0)
- ;;=B18.2^^99^1337^3
- ;;^UTILITY(U,$J,358.3,32383,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32383,1,3,0)
- ;;=3^Hepatitis C,Chr
- ;;^UTILITY(U,$J,358.3,32383,1,4,0)
- ;;=4^B18.2
- ;;^UTILITY(U,$J,358.3,32383,2)
- ;;=^5000548
- ;;^UTILITY(U,$J,358.3,32384,0)
- ;;=B35.6^^99^1337^4
- ;;^UTILITY(U,$J,358.3,32384,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32384,1,3,0)
- ;;=3^Tinea Cruris
- ;;^UTILITY(U,$J,358.3,32384,1,4,0)
- ;;=4^B35.6
- ;;^UTILITY(U,$J,358.3,32384,2)
- ;;=^119711
- ;;^UTILITY(U,$J,358.3,32385,0)
- ;;=B35.3^^99^1337^5
- ;;^UTILITY(U,$J,358.3,32385,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32385,1,3,0)
- ;;=3^Tinea Pedis
- ;;^UTILITY(U,$J,358.3,32385,1,4,0)
- ;;=4^B35.3
- ;;^UTILITY(U,$J,358.3,32385,2)
- ;;=^119732
- ;;^UTILITY(U,$J,358.3,32386,0)
- ;;=B97.89^^99^1337^6
- ;;^UTILITY(U,$J,358.3,32386,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32386,1,3,0)
- ;;=3^Viral Agents as the Cause of Diseases Classified Elsewhere
- ;;^UTILITY(U,$J,358.3,32386,1,4,0)
- ;;=4^B97.89
- ;;^UTILITY(U,$J,358.3,32386,2)
- ;;=^5000879
- ;;^UTILITY(U,$J,358.3,32387,0)
- ;;=B02.9^^99^1337^7
- ;;^UTILITY(U,$J,358.3,32387,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32387,1,3,0)
- ;;=3^Zoster w/o Complications
- ;;^UTILITY(U,$J,358.3,32387,1,4,0)
- ;;=4^B02.9
- ;;^UTILITY(U,$J,358.3,32387,2)
- ;;=^5000501
- ;;^UTILITY(U,$J,358.3,32388,0)
- ;;=C44.91^^99^1338^1
- ;;^UTILITY(U,$J,358.3,32388,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32388,1,3,0)
- ;;=3^Basal cell carcinoma of skin, unspecified
- ;;^UTILITY(U,$J,358.3,32388,1,4,0)
- ;;=4^C44.91
- ;;^UTILITY(U,$J,358.3,32388,2)
- ;;=^5001092
- ;;^UTILITY(U,$J,358.3,32389,0)
- ;;=D17.9^^99^1338^2
- ;;^UTILITY(U,$J,358.3,32389,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32389,1,3,0)
- ;;=3^Benign lipomatous neoplasm, unspecified
- ;;^UTILITY(U,$J,358.3,32389,1,4,0)
- ;;=4^D17.9
- ;;^UTILITY(U,$J,358.3,32389,2)
- ;;=^5002020
- ;;^UTILITY(U,$J,358.3,32390,0)
- ;;=C67.9^^99^1338^3
- ;;^UTILITY(U,$J,358.3,32390,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32390,1,3,0)
- ;;=3^Malignant neoplasm of bladder, unspecified
- ;;^UTILITY(U,$J,358.3,32390,1,4,0)
- ;;=4^C67.9
- ;;^UTILITY(U,$J,358.3,32390,2)
- ;;=^5001263
- ;;^UTILITY(U,$J,358.3,32391,0)
- ;;=C18.9^^99^1338^4
- ;;^UTILITY(U,$J,358.3,32391,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32391,1,3,0)
- ;;=3^Malignant neoplasm of colon, unspecified
- ;;^UTILITY(U,$J,358.3,32391,1,4,0)
- ;;=4^C18.9
- ;;^UTILITY(U,$J,358.3,32391,2)
- ;;=^5000929
- ;;^UTILITY(U,$J,358.3,32392,0)
- ;;=C15.9^^99^1338^5
- ;;^UTILITY(U,$J,358.3,32392,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32392,1,3,0)
- ;;=3^Malignant neoplasm of esophagus, unspecified
- ;;^UTILITY(U,$J,358.3,32392,1,4,0)
- ;;=4^C15.9
- ;;^UTILITY(U,$J,358.3,32392,2)
- ;;=^5000919
- ;;^UTILITY(U,$J,358.3,32393,0)
- ;;=C32.9^^99^1338^6
- ;;^UTILITY(U,$J,358.3,32393,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32393,1,3,0)
- ;;=3^Malignant neoplasm of larynx, unspecified
- ;;^UTILITY(U,$J,358.3,32393,1,4,0)
- ;;=4^C32.9
- ;;^UTILITY(U,$J,358.3,32393,2)
- ;;=^5000956
- ;;^UTILITY(U,$J,358.3,32394,0)
- ;;=C34.92^^99^1338^7
- ;;^UTILITY(U,$J,358.3,32394,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32394,1,3,0)
- ;;=3^Malignant neoplasm of left bronchus/lung,unspec part
- ;;^UTILITY(U,$J,358.3,32394,1,4,0)
- ;;=4^C34.92
- ;;^UTILITY(U,$J,358.3,32394,2)
- ;;=^5000968
- ;;^UTILITY(U,$J,358.3,32395,0)
- ;;=C50.912^^99^1338^8
- ;;^UTILITY(U,$J,358.3,32395,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32395,1,3,0)
- ;;=3^Malignant neoplasm of left female breast,unspec site
- ;;^UTILITY(U,$J,358.3,32395,1,4,0)
- ;;=4^C50.912
- ;;^UTILITY(U,$J,358.3,32395,2)
- ;;=^5001196
- ;;^UTILITY(U,$J,358.3,32396,0)
- ;;=C64.2^^99^1338^9
- ;;^UTILITY(U,$J,358.3,32396,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32396,1,3,0)
- ;;=3^Malignant neoplasm of left kidney, except renal pelvis
- ;;^UTILITY(U,$J,358.3,32396,1,4,0)
- ;;=4^C64.2
- ;;^UTILITY(U,$J,358.3,32396,2)
- ;;=^5001249
- ;;^UTILITY(U,$J,358.3,32397,0)
- ;;=C61.^^99^1338^10
- ;;^UTILITY(U,$J,358.3,32397,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32397,1,3,0)
- ;;=3^Malignant neoplasm of prostate
- ;;^UTILITY(U,$J,358.3,32397,1,4,0)
- ;;=4^C61.
- ;;^UTILITY(U,$J,358.3,32397,2)
- ;;=^267239
- ;;^UTILITY(U,$J,358.3,32398,0)
- ;;=C34.91^^99^1338^11
- ;;^UTILITY(U,$J,358.3,32398,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32398,1,3,0)
- ;;=3^Malignant neoplasm of right bronchus/lung,unspec part
- ;;^UTILITY(U,$J,358.3,32398,1,4,0)
- ;;=4^C34.91
- ;;^UTILITY(U,$J,358.3,32398,2)
- ;;=^5000967
- ;;^UTILITY(U,$J,358.3,32399,0)
- ;;=C50.911^^99^1338^12
- ;;^UTILITY(U,$J,358.3,32399,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32399,1,3,0)
- ;;=3^Malignant neoplasm of right female breast,unspec site
- ;;^UTILITY(U,$J,358.3,32399,1,4,0)
- ;;=4^C50.911
- ;;^UTILITY(U,$J,358.3,32399,2)
- ;;=^5001195
- ;;^UTILITY(U,$J,358.3,32400,0)
- ;;=C64.1^^99^1338^13
- ;;^UTILITY(U,$J,358.3,32400,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32400,1,3,0)
- ;;=3^Malignant neoplasm of right kidney, except renal pelvis
- ;;^UTILITY(U,$J,358.3,32400,1,4,0)
- ;;=4^C64.1
- ;;^UTILITY(U,$J,358.3,32400,2)
- ;;=^5001248
- ;;^UTILITY(U,$J,358.3,32401,0)
- ;;=C44.99^^99^1338^14
- ;;^UTILITY(U,$J,358.3,32401,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32401,1,3,0)
- ;;=3^Malignant neoplasm of skin,Oth Spec
- ;;^UTILITY(U,$J,358.3,32401,1,4,0)
- ;;=4^C44.99
- ;;^UTILITY(U,$J,358.3,32401,2)
- ;;=^5001094
- ;;^UTILITY(U,$J,358.3,32402,0)
- ;;=C79.51^^99^1338^15
- ;;^UTILITY(U,$J,358.3,32402,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32402,1,3,0)
- ;;=3^Secondary malignant neoplasm of bone
- ;;^UTILITY(U,$J,358.3,32402,1,4,0)
- ;;=4^C79.51
- ;;^UTILITY(U,$J,358.3,32402,2)
- ;;=^5001350
- ;;^UTILITY(U,$J,358.3,32403,0)
- ;;=C79.52^^99^1338^16
- ;;^UTILITY(U,$J,358.3,32403,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32403,1,3,0)
- ;;=3^Secondary malignant neoplasm of bone marrow
- ;;^UTILITY(U,$J,358.3,32403,1,4,0)
- ;;=4^C79.52
- ;;^UTILITY(U,$J,358.3,32403,2)
- ;;=^5001351
- ;;^UTILITY(U,$J,358.3,32404,0)
- ;;=D47.4^^99^1339^29
- ;;^UTILITY(U,$J,358.3,32404,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32404,1,3,0)
- ;;=3^Osteomyelofibrosis
- ;;^UTILITY(U,$J,358.3,32404,1,4,0)
- ;;=4^D47.4
- ;;^UTILITY(U,$J,358.3,32404,2)
- ;;=^5002259
- ;;^UTILITY(U,$J,358.3,32405,0)
- ;;=D50.9^^99^1339^1
- ;;^UTILITY(U,$J,358.3,32405,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32405,1,3,0)
- ;;=3^Anemia, iron deficiency
- ;;^UTILITY(U,$J,358.3,32405,1,4,0)
- ;;=4^D50.9
- ;;^UTILITY(U,$J,358.3,32405,2)
- ;;=^5002283
- ;;^UTILITY(U,$J,358.3,32406,0)
- ;;=D64.9^^99^1339^2
- ;;^UTILITY(U,$J,358.3,32406,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32406,1,3,0)
- ;;=3^Anemia, unspecified
- ;;^UTILITY(U,$J,358.3,32406,1,4,0)
- ;;=4^D64.9
- ;;^UTILITY(U,$J,358.3,32406,2)
- ;;=^5002351
- ;;^UTILITY(U,$J,358.3,32407,0)
- ;;=D75.89^^99^1339^3
- ;;^UTILITY(U,$J,358.3,32407,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32407,1,3,0)
- ;;=3^Blood & blood forming organ disease, oth spec
- ;;^UTILITY(U,$J,358.3,32407,1,4,0)
- ;;=4^D75.89
- ;;^UTILITY(U,$J,358.3,32407,2)
- ;;=^5002392
- ;;^UTILITY(U,$J,358.3,32408,0)
- ;;=D89.2^^99^1339^16
- ;;^UTILITY(U,$J,358.3,32408,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32408,1,3,0)
- ;;=3^Hypergammaglobulinemia, unspecified
- ;;^UTILITY(U,$J,358.3,32408,1,4,0)
- ;;=4^D89.2
- ;;^UTILITY(U,$J,358.3,32408,2)
- ;;=^5002455
- ;;^UTILITY(U,$J,358.3,32409,0)
- ;;=E03.9^^99^1339^24
- ;;^UTILITY(U,$J,358.3,32409,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32409,1,3,0)
- ;;=3^Hypothyroidism, unspecified
- ;;^UTILITY(U,$J,358.3,32409,1,4,0)
- ;;=4^E03.9
- ;;^UTILITY(U,$J,358.3,32409,2)
- ;;=^5002476
- ;;^UTILITY(U,$J,358.3,32410,0)
- ;;=E05.90^^99^1339^30
- ;;^UTILITY(U,$J,358.3,32410,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32410,1,3,0)
- ;;=3^Thyrotoxicosis w/o thyrotoxic crisis/storm
- ;;^UTILITY(U,$J,358.3,32410,1,4,0)
- ;;=4^E05.90
- ;;^UTILITY(U,$J,358.3,32410,2)
- ;;=^5002492
- ;;^UTILITY(U,$J,358.3,32411,0)
- ;;=E08.42^^99^1339^10
- ;;^UTILITY(U,$J,358.3,32411,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32411,1,3,0)
- ;;=3^DM d/t underlying condition w/ diabetic polyneuropathy
- ;;^UTILITY(U,$J,358.3,32411,1,4,0)
- ;;=4^E08.42
- ;;^UTILITY(U,$J,358.3,32411,2)
- ;;=^5002524
- ;;^UTILITY(U,$J,358.3,32412,0)
- ;;=E09.42^^99^1339^11
- ;;^UTILITY(U,$J,358.3,32412,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32412,1,3,0)
- ;;=3^DM drug-induced w/ neurological compl w/ diabetic polyneuropathy
- ;;^UTILITY(U,$J,358.3,32412,1,4,0)
- ;;=4^E09.42
- ;;^UTILITY(U,$J,358.3,32412,2)
- ;;=^5002566
- ;;^UTILITY(U,$J,358.3,32413,0)
- ;;=E10.42^^99^1339^4
- ;;^UTILITY(U,$J,358.3,32413,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32413,1,3,0)
- ;;=3^DM Type 1 w/ diabetic polyneuropathy
- ;;^UTILITY(U,$J,358.3,32413,1,4,0)
- ;;=4^E10.42
- ;;^UTILITY(U,$J,358.3,32413,2)
- ;;=^5002606
- ;;^UTILITY(U,$J,358.3,32414,0)
- ;;=E10.65^^99^1339^5
- ;;^UTILITY(U,$J,358.3,32414,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32414,1,3,0)
- ;;=3^DM Type 1 w/ hyperglycemia
- ;;^UTILITY(U,$J,358.3,32414,1,4,0)
- ;;=4^E10.65
- ;;^UTILITY(U,$J,358.3,32414,2)
- ;;=^5002623
- ;;^UTILITY(U,$J,358.3,32415,0)
- ;;=E10.9^^99^1339^6
- ;;^UTILITY(U,$J,358.3,32415,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32415,1,3,0)
- ;;=3^DM Type 1 w/o complications
- ;;^UTILITY(U,$J,358.3,32415,1,4,0)
- ;;=4^E10.9
- ;;^UTILITY(U,$J,358.3,32415,2)
- ;;=^5002626
- ;;^UTILITY(U,$J,358.3,32416,0)
- ;;=E11.42^^99^1339^7
- ;;^UTILITY(U,$J,358.3,32416,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32416,1,3,0)
- ;;=3^DM Type 2 w/ diabetic polyneuropathy
- ;;^UTILITY(U,$J,358.3,32416,1,4,0)
- ;;=4^E11.42
- ;;^UTILITY(U,$J,358.3,32416,2)
- ;;=^5002646
- ;;^UTILITY(U,$J,358.3,32417,0)
- ;;=E11.65^^99^1339^8
- ;;^UTILITY(U,$J,358.3,32417,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32417,1,3,0)
- ;;=3^DM Type 2 w/ hyperglycemia
- ;;^UTILITY(U,$J,358.3,32417,1,4,0)
- ;;=4^E11.65
- ;;^UTILITY(U,$J,358.3,32417,2)
- ;;=^5002663
- ;;^UTILITY(U,$J,358.3,32418,0)
- ;;=E11.9^^99^1339^9
- ;;^UTILITY(U,$J,358.3,32418,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32418,1,3,0)
- ;;=3^DM Type 2 w/o complications
- ;;^UTILITY(U,$J,358.3,32418,1,4,0)
- ;;=4^E11.9
- ;;^UTILITY(U,$J,358.3,32418,2)
- ;;=^5002666
- ;;^UTILITY(U,$J,358.3,32419,0)
- ;;=E13.42^^99^1339^12
- ;;^UTILITY(U,$J,358.3,32419,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32419,1,3,0)
- ;;=3^DM oth w/ diabetic polyneuropathy
- ;;^UTILITY(U,$J,358.3,32419,1,4,0)
- ;;=4^E13.42
- ;;^UTILITY(U,$J,358.3,32419,2)
- ;;=^5002686
- ;;^UTILITY(U,$J,358.3,32420,0)
- ;;=E16.2^^99^1339^22
- ;;^UTILITY(U,$J,358.3,32420,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32420,1,3,0)
- ;;=3^Hypoglycemia, unspecified
- ;;^UTILITY(U,$J,358.3,32420,1,4,0)
- ;;=4^E16.2
- ;;^UTILITY(U,$J,358.3,32420,2)
- ;;=^5002708
- ;;^UTILITY(U,$J,358.3,32421,0)
- ;;=E46.^^99^1339^26
- ;;^UTILITY(U,$J,358.3,32421,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32421,1,3,0)
- ;;=3^Malnutrition, protein-calorie, unspec
- ;;^UTILITY(U,$J,358.3,32421,1,4,0)
- ;;=4^E46.
- ;;^UTILITY(U,$J,358.3,32421,2)
- ;;=^5002790
- ;;^UTILITY(U,$J,358.3,32422,0)
- ;;=E53.8^^99^1339^31
- ;;^UTILITY(U,$J,358.3,32422,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32422,1,3,0)
- ;;=3^Vitamin B group deficiency
- ;;^UTILITY(U,$J,358.3,32422,1,4,0)
- ;;=4^E53.8
- ;;^UTILITY(U,$J,358.3,32422,2)
- ;;=^5002797
- ;;^UTILITY(U,$J,358.3,32423,0)
- ;;=E66.01^^99^1339^27
- ;;^UTILITY(U,$J,358.3,32423,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32423,1,3,0)
- ;;=3^Obesity, morbid
- ;;^UTILITY(U,$J,358.3,32423,1,4,0)
- ;;=4^E66.01
- ;;^UTILITY(U,$J,358.3,32423,2)
- ;;=^5002826
- ;;^UTILITY(U,$J,358.3,32424,0)
- ;;=E66.9^^99^1339^28
- ;;^UTILITY(U,$J,358.3,32424,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32424,1,3,0)
- ;;=3^Obesity, unspecified
- ;;^UTILITY(U,$J,358.3,32424,1,4,0)
- ;;=4^E66.9
- ;;^UTILITY(U,$J,358.3,32424,2)
- ;;=^5002832
- ;;^UTILITY(U,$J,358.3,32425,0)
- ;;=E74.39^^99^1339^25
- ;;^UTILITY(U,$J,358.3,32425,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32425,1,3,0)
- ;;=3^Intestinal carbohydrate absorption disorder, other
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0CW 19748 printed Feb 18, 2025@23:12:35 Page 2
- IBDEI0CW ; ; 03-MAY-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,32356,1,4,0)
- +2 ;;=4^L20.89
- +3 ;;^UTILITY(U,$J,358.3,32356,2)
- +4 ;;=^5009112
- +5 ;;^UTILITY(U,$J,358.3,32357,0)
- +6 ;;=L25.9^^97^1335^15
- +7 ;;^UTILITY(U,$J,358.3,32357,1,0)
- +8 ;;=^358.31IA^4^2
- +9 ;;^UTILITY(U,$J,358.3,32357,1,3,0)
- +10 ;;=3^Contact Dermatitis,Unspec
- +11 ;;^UTILITY(U,$J,358.3,32357,1,4,0)
- +12 ;;=4^L25.9
- +13 ;;^UTILITY(U,$J,358.3,32357,2)
- +14 ;;=^5133647
- +15 ;;^UTILITY(U,$J,358.3,32358,0)
- +16 ;;=L40.0^^97^1335^16
- +17 ;;^UTILITY(U,$J,358.3,32358,1,0)
- +18 ;;=^358.31IA^4^2
- +19 ;;^UTILITY(U,$J,358.3,32358,1,3,0)
- +20 ;;=3^Psoriasis
- +21 ;;^UTILITY(U,$J,358.3,32358,1,4,0)
- +22 ;;=4^L40.0
- +23 ;;^UTILITY(U,$J,358.3,32358,2)
- +24 ;;=^5009160
- +25 ;;^UTILITY(U,$J,358.3,32359,0)
- +26 ;;=L29.9^^97^1335^17
- +27 ;;^UTILITY(U,$J,358.3,32359,1,0)
- +28 ;;=^358.31IA^4^2
- +29 ;;^UTILITY(U,$J,358.3,32359,1,3,0)
- +30 ;;=3^Pruritus
- +31 ;;^UTILITY(U,$J,358.3,32359,1,4,0)
- +32 ;;=4^L29.9
- +33 ;;^UTILITY(U,$J,358.3,32359,2)
- +34 ;;=^5009153
- +35 ;;^UTILITY(U,$J,358.3,32360,0)
- +36 ;;=L85.3^^97^1335^18
- +37 ;;^UTILITY(U,$J,358.3,32360,1,0)
- +38 ;;=^358.31IA^4^2
- +39 ;;^UTILITY(U,$J,358.3,32360,1,3,0)
- +40 ;;=3^Xerosis
- +41 ;;^UTILITY(U,$J,358.3,32360,1,4,0)
- +42 ;;=4^L85.3
- +43 ;;^UTILITY(U,$J,358.3,32360,2)
- +44 ;;=^5009323
- +45 ;;^UTILITY(U,$J,358.3,32361,0)
- +46 ;;=L30.2^^97^1335^19
- +47 ;;^UTILITY(U,$J,358.3,32361,1,0)
- +48 ;;=^358.31IA^4^2
- +49 ;;^UTILITY(U,$J,358.3,32361,1,3,0)
- +50 ;;=3^Cutaneous Autosensitization/ld
- +51 ;;^UTILITY(U,$J,358.3,32361,1,4,0)
- +52 ;;=4^L30.2
- +53 ;;^UTILITY(U,$J,358.3,32361,2)
- +54 ;;=^5009155
- +55 ;;^UTILITY(U,$J,358.3,32362,0)
- +56 ;;=L72.0^^97^1335^20
- +57 ;;^UTILITY(U,$J,358.3,32362,1,0)
- +58 ;;=^358.31IA^4^2
- +59 ;;^UTILITY(U,$J,358.3,32362,1,3,0)
- +60 ;;=3^Epidermal Cyst
- +61 ;;^UTILITY(U,$J,358.3,32362,1,4,0)
- +62 ;;=4^L72.0
- +63 ;;^UTILITY(U,$J,358.3,32362,2)
- +64 ;;=^5009277
- +65 ;;^UTILITY(U,$J,358.3,32363,0)
- +66 ;;=L73.9^^97^1335^21
- +67 ;;^UTILITY(U,$J,358.3,32363,1,0)
- +68 ;;=^358.31IA^4^2
- +69 ;;^UTILITY(U,$J,358.3,32363,1,3,0)
- +70 ;;=3^Follicular Disorder/Folliculitis
- +71 ;;^UTILITY(U,$J,358.3,32363,1,4,0)
- +72 ;;=4^L73.9
- +73 ;;^UTILITY(U,$J,358.3,32363,2)
- +74 ;;=^5009286
- +75 ;;^UTILITY(U,$J,358.3,32364,0)
- +76 ;;=L70.0^^97^1335^22
- +77 ;;^UTILITY(U,$J,358.3,32364,1,0)
- +78 ;;=^358.31IA^4^2
- +79 ;;^UTILITY(U,$J,358.3,32364,1,3,0)
- +80 ;;=3^Acne
- +81 ;;^UTILITY(U,$J,358.3,32364,1,4,0)
- +82 ;;=4^L70.0
- +83 ;;^UTILITY(U,$J,358.3,32364,2)
- +84 ;;=^5009268
- +85 ;;^UTILITY(U,$J,358.3,32365,0)
- +86 ;;=L71.8^^97^1335^23
- +87 ;;^UTILITY(U,$J,358.3,32365,1,0)
- +88 ;;=^358.31IA^4^2
- +89 ;;^UTILITY(U,$J,358.3,32365,1,3,0)
- +90 ;;=3^Rosacea
- +91 ;;^UTILITY(U,$J,358.3,32365,1,4,0)
- +92 ;;=4^L71.8
- +93 ;;^UTILITY(U,$J,358.3,32365,2)
- +94 ;;=^5009275
- +95 ;;^UTILITY(U,$J,358.3,32366,0)
- +96 ;;=L91.0^^97^1335^24
- +97 ;;^UTILITY(U,$J,358.3,32366,1,0)
- +98 ;;=^358.31IA^4^2
- +99 ;;^UTILITY(U,$J,358.3,32366,1,3,0)
- +100 ;;=3^Hypertrophic Scar
- +101 ;;^UTILITY(U,$J,358.3,32366,1,4,0)
- +102 ;;=4^L91.0
- +103 ;;^UTILITY(U,$J,358.3,32366,2)
- +104 ;;=^5009459
- +105 ;;^UTILITY(U,$J,358.3,32367,0)
- +106 ;;=L91.8^^97^1335^25
- +107 ;;^UTILITY(U,$J,358.3,32367,1,0)
- +108 ;;=^358.31IA^4^2
- +109 ;;^UTILITY(U,$J,358.3,32367,1,3,0)
- +110 ;;=3^Skin Tag/Oth Hypertrophic Disorder of Skin
- +111 ;;^UTILITY(U,$J,358.3,32367,1,4,0)
- +112 ;;=4^L91.8
- +113 ;;^UTILITY(U,$J,358.3,32367,2)
- +114 ;;=^5009460
- +115 ;;^UTILITY(U,$J,358.3,32368,0)
- +116 ;;=I87.2^^97^1335^26
- +117 ;;^UTILITY(U,$J,358.3,32368,1,0)
- +118 ;;=^358.31IA^4^2
- +119 ;;^UTILITY(U,$J,358.3,32368,1,3,0)
- +120 ;;=3^Stasis Dermatitis/Venous Insufficiency
- +121 ;;^UTILITY(U,$J,358.3,32368,1,4,0)
- +122 ;;=4^I87.2
- +123 ;;^UTILITY(U,$J,358.3,32368,2)
- +124 ;;=^5008047
- +125 ;;^UTILITY(U,$J,358.3,32369,0)
- +126 ;;=D69.8^^97^1335^27
- +127 ;;^UTILITY(U,$J,358.3,32369,1,0)
- +128 ;;=^358.31IA^4^2
- +129 ;;^UTILITY(U,$J,358.3,32369,1,3,0)
- +130 ;;=3^Purpura,Hemorrhagic Condition
- +131 ;;^UTILITY(U,$J,358.3,32369,1,4,0)
- +132 ;;=4^D69.8
- +133 ;;^UTILITY(U,$J,358.3,32369,2)
- +134 ;;=^88074
- +135 ;;^UTILITY(U,$J,358.3,32370,0)
- +136 ;;=L08.9^^97^1335^28
- +137 ;;^UTILITY(U,$J,358.3,32370,1,0)
- +138 ;;=^358.31IA^4^2
- +139 ;;^UTILITY(U,$J,358.3,32370,1,3,0)
- +140 ;;=3^Pyoderma
- +141 ;;^UTILITY(U,$J,358.3,32370,1,4,0)
- +142 ;;=4^L08.9
- +143 ;;^UTILITY(U,$J,358.3,32370,2)
- +144 ;;=^5009082
- +145 ;;^UTILITY(U,$J,358.3,32371,0)
- +146 ;;=L01.00^^97^1335^29
- +147 ;;^UTILITY(U,$J,358.3,32371,1,0)
- +148 ;;=^358.31IA^4^2
- +149 ;;^UTILITY(U,$J,358.3,32371,1,3,0)
- +150 ;;=3^Impetigo
- +151 ;;^UTILITY(U,$J,358.3,32371,1,4,0)
- +152 ;;=4^L01.00
- +153 ;;^UTILITY(U,$J,358.3,32371,2)
- +154 ;;=^5008938
- +155 ;;^UTILITY(U,$J,358.3,32372,0)
- +156 ;;=L03.90^^97^1335^30
- +157 ;;^UTILITY(U,$J,358.3,32372,1,0)
- +158 ;;=^358.31IA^4^2
- +159 ;;^UTILITY(U,$J,358.3,32372,1,3,0)
- +160 ;;=3^Cellulitis
- +161 ;;^UTILITY(U,$J,358.3,32372,1,4,0)
- +162 ;;=4^L03.90
- +163 ;;^UTILITY(U,$J,358.3,32372,2)
- +164 ;;=^5009067
- +165 ;;^UTILITY(U,$J,358.3,32373,0)
- +166 ;;=Z79.1^^97^1335^31
- +167 ;;^UTILITY(U,$J,358.3,32373,1,0)
- +168 ;;=^358.31IA^4^2
- +169 ;;^UTILITY(U,$J,358.3,32373,1,3,0)
- +170 ;;=3^Long Term Use NSAID/Oth Health Status
- +171 ;;^UTILITY(U,$J,358.3,32373,1,4,0)
- +172 ;;=4^Z79.1
- +173 ;;^UTILITY(U,$J,358.3,32373,2)
- +174 ;;=^5063332
- +175 ;;^UTILITY(U,$J,358.3,32374,0)
- +176 ;;=Z79.899^^97^1335^32
- +177 ;;^UTILITY(U,$J,358.3,32374,1,0)
- +178 ;;=^358.31IA^4^2
- +179 ;;^UTILITY(U,$J,358.3,32374,1,3,0)
- +180 ;;=3^Long Term Use Oth Drug
- +181 ;;^UTILITY(U,$J,358.3,32374,1,4,0)
- +182 ;;=4^Z79.899
- +183 ;;^UTILITY(U,$J,358.3,32374,2)
- +184 ;;=^5063343
- +185 ;;^UTILITY(U,$J,358.3,32375,0)
- +186 ;;=Z80.8^^97^1335^33
- +187 ;;^UTILITY(U,$J,358.3,32375,1,0)
- +188 ;;=^358.31IA^4^2
- +189 ;;^UTILITY(U,$J,358.3,32375,1,3,0)
- +190 ;;=3^Family Hx of Melanoma
- +191 ;;^UTILITY(U,$J,358.3,32375,1,4,0)
- +192 ;;=4^Z80.8
- +193 ;;^UTILITY(U,$J,358.3,32375,2)
- +194 ;;=^5063356
- +195 ;;^UTILITY(U,$J,358.3,32376,0)
- +196 ;;=Z48.817^^97^1335^34
- +197 ;;^UTILITY(U,$J,358.3,32376,1,0)
- +198 ;;=^358.31IA^4^2
- +199 ;;^UTILITY(U,$J,358.3,32376,1,3,0)
- +200 ;;=3^Surgical Aftercare Skin/Subcutaneous Tissue
- +201 ;;^UTILITY(U,$J,358.3,32376,1,4,0)
- +202 ;;=4^Z48.817
- +203 ;;^UTILITY(U,$J,358.3,32376,2)
- +204 ;;=^5063054
- +205 ;;^UTILITY(U,$J,358.3,32377,0)
- +206 ;;=R99.^^97^1335^35
- +207 ;;^UTILITY(U,$J,358.3,32377,1,0)
- +208 ;;=^358.31IA^4^2
- +209 ;;^UTILITY(U,$J,358.3,32377,1,3,0)
- +210 ;;=3^Dead Unknown Mortality
- +211 ;;^UTILITY(U,$J,358.3,32377,1,4,0)
- +212 ;;=4^R99.
- +213 ;;^UTILITY(U,$J,358.3,32377,2)
- +214 ;;=^5019750
- +215 ;;^UTILITY(U,$J,358.3,32378,0)
- +216 ;;=Z85.9^^97^1335^36
- +217 ;;^UTILITY(U,$J,358.3,32378,1,0)
- +218 ;;=^358.31IA^4^2
- +219 ;;^UTILITY(U,$J,358.3,32378,1,3,0)
- +220 ;;=3^Personal Hx of Unspec Neoplasm/Cancer
- +221 ;;^UTILITY(U,$J,358.3,32378,1,4,0)
- +222 ;;=4^Z85.9
- +223 ;;^UTILITY(U,$J,358.3,32378,2)
- +224 ;;=^5063452
- +225 ;;^UTILITY(U,$J,358.3,32379,0)
- +226 ;;=C79.9^^97^1335^37
- +227 ;;^UTILITY(U,$J,358.3,32379,1,0)
- +228 ;;=^358.31IA^4^2
- +229 ;;^UTILITY(U,$J,358.3,32379,1,3,0)
- +230 ;;=3^Metastatic Cancer Unspec
- +231 ;;^UTILITY(U,$J,358.3,32379,1,4,0)
- +232 ;;=4^C79.9
- +233 ;;^UTILITY(U,$J,358.3,32379,2)
- +234 ;;=^5133344
- +235 ;;^UTILITY(U,$J,358.3,32380,0)
- +236 ;;=Q3014^^98^1336^1^^^^1
- +237 ;;^UTILITY(U,$J,358.3,32380,1,0)
- +238 ;;=^358.31IA^3^2
- +239 ;;^UTILITY(U,$J,358.3,32380,1,2,0)
- +240 ;;=2^Q3014
- +241 ;;^UTILITY(U,$J,358.3,32380,1,3,0)
- +242 ;;=3^Telehealth Fac Fee-Pt Site
- +243 ;;^UTILITY(U,$J,358.3,32381,0)
- +244 ;;=B19.10^^99^1337^1
- +245 ;;^UTILITY(U,$J,358.3,32381,1,0)
- +246 ;;=^358.31IA^4^2
- +247 ;;^UTILITY(U,$J,358.3,32381,1,3,0)
- +248 ;;=3^Hepatitis B w/o Hepatic Coma
- +249 ;;^UTILITY(U,$J,358.3,32381,1,4,0)
- +250 ;;=4^B19.10
- +251 ;;^UTILITY(U,$J,358.3,32381,2)
- +252 ;;=^5000552
- +253 ;;^UTILITY(U,$J,358.3,32382,0)
- +254 ;;=B17.10^^99^1337^2
- +255 ;;^UTILITY(U,$J,358.3,32382,1,0)
- +256 ;;=^358.31IA^4^2
- +257 ;;^UTILITY(U,$J,358.3,32382,1,3,0)
- +258 ;;=3^Hepatitis C w/o Hepatic Coma,Acute
- +259 ;;^UTILITY(U,$J,358.3,32382,1,4,0)
- +260 ;;=4^B17.10
- +261 ;;^UTILITY(U,$J,358.3,32382,2)
- +262 ;;=^5000542
- +263 ;;^UTILITY(U,$J,358.3,32383,0)
- +264 ;;=B18.2^^99^1337^3
- +265 ;;^UTILITY(U,$J,358.3,32383,1,0)
- +266 ;;=^358.31IA^4^2
- +267 ;;^UTILITY(U,$J,358.3,32383,1,3,0)
- +268 ;;=3^Hepatitis C,Chr
- +269 ;;^UTILITY(U,$J,358.3,32383,1,4,0)
- +270 ;;=4^B18.2
- +271 ;;^UTILITY(U,$J,358.3,32383,2)
- +272 ;;=^5000548
- +273 ;;^UTILITY(U,$J,358.3,32384,0)
- +274 ;;=B35.6^^99^1337^4
- +275 ;;^UTILITY(U,$J,358.3,32384,1,0)
- +276 ;;=^358.31IA^4^2
- +277 ;;^UTILITY(U,$J,358.3,32384,1,3,0)
- +278 ;;=3^Tinea Cruris
- +279 ;;^UTILITY(U,$J,358.3,32384,1,4,0)
- +280 ;;=4^B35.6
- +281 ;;^UTILITY(U,$J,358.3,32384,2)
- +282 ;;=^119711
- +283 ;;^UTILITY(U,$J,358.3,32385,0)
- +284 ;;=B35.3^^99^1337^5
- +285 ;;^UTILITY(U,$J,358.3,32385,1,0)
- +286 ;;=^358.31IA^4^2
- +287 ;;^UTILITY(U,$J,358.3,32385,1,3,0)
- +288 ;;=3^Tinea Pedis
- +289 ;;^UTILITY(U,$J,358.3,32385,1,4,0)
- +290 ;;=4^B35.3
- +291 ;;^UTILITY(U,$J,358.3,32385,2)
- +292 ;;=^119732
- +293 ;;^UTILITY(U,$J,358.3,32386,0)
- +294 ;;=B97.89^^99^1337^6
- +295 ;;^UTILITY(U,$J,358.3,32386,1,0)
- +296 ;;=^358.31IA^4^2
- +297 ;;^UTILITY(U,$J,358.3,32386,1,3,0)
- +298 ;;=3^Viral Agents as the Cause of Diseases Classified Elsewhere
- +299 ;;^UTILITY(U,$J,358.3,32386,1,4,0)
- +300 ;;=4^B97.89
- +301 ;;^UTILITY(U,$J,358.3,32386,2)
- +302 ;;=^5000879
- +303 ;;^UTILITY(U,$J,358.3,32387,0)
- +304 ;;=B02.9^^99^1337^7
- +305 ;;^UTILITY(U,$J,358.3,32387,1,0)
- +306 ;;=^358.31IA^4^2
- +307 ;;^UTILITY(U,$J,358.3,32387,1,3,0)
- +308 ;;=3^Zoster w/o Complications
- +309 ;;^UTILITY(U,$J,358.3,32387,1,4,0)
- +310 ;;=4^B02.9
- +311 ;;^UTILITY(U,$J,358.3,32387,2)
- +312 ;;=^5000501
- +313 ;;^UTILITY(U,$J,358.3,32388,0)
- +314 ;;=C44.91^^99^1338^1
- +315 ;;^UTILITY(U,$J,358.3,32388,1,0)
- +316 ;;=^358.31IA^4^2
- +317 ;;^UTILITY(U,$J,358.3,32388,1,3,0)
- +318 ;;=3^Basal cell carcinoma of skin, unspecified
- +319 ;;^UTILITY(U,$J,358.3,32388,1,4,0)
- +320 ;;=4^C44.91
- +321 ;;^UTILITY(U,$J,358.3,32388,2)
- +322 ;;=^5001092
- +323 ;;^UTILITY(U,$J,358.3,32389,0)
- +324 ;;=D17.9^^99^1338^2
- +325 ;;^UTILITY(U,$J,358.3,32389,1,0)
- +326 ;;=^358.31IA^4^2
- +327 ;;^UTILITY(U,$J,358.3,32389,1,3,0)
- +328 ;;=3^Benign lipomatous neoplasm, unspecified
- +329 ;;^UTILITY(U,$J,358.3,32389,1,4,0)
- +330 ;;=4^D17.9
- +331 ;;^UTILITY(U,$J,358.3,32389,2)
- +332 ;;=^5002020
- +333 ;;^UTILITY(U,$J,358.3,32390,0)
- +334 ;;=C67.9^^99^1338^3
- +335 ;;^UTILITY(U,$J,358.3,32390,1,0)
- +336 ;;=^358.31IA^4^2
- +337 ;;^UTILITY(U,$J,358.3,32390,1,3,0)
- +338 ;;=3^Malignant neoplasm of bladder, unspecified
- +339 ;;^UTILITY(U,$J,358.3,32390,1,4,0)
- +340 ;;=4^C67.9
- +341 ;;^UTILITY(U,$J,358.3,32390,2)
- +342 ;;=^5001263
- +343 ;;^UTILITY(U,$J,358.3,32391,0)
- +344 ;;=C18.9^^99^1338^4
- +345 ;;^UTILITY(U,$J,358.3,32391,1,0)
- +346 ;;=^358.31IA^4^2
- +347 ;;^UTILITY(U,$J,358.3,32391,1,3,0)
- +348 ;;=3^Malignant neoplasm of colon, unspecified
- +349 ;;^UTILITY(U,$J,358.3,32391,1,4,0)
- +350 ;;=4^C18.9
- +351 ;;^UTILITY(U,$J,358.3,32391,2)
- +352 ;;=^5000929
- +353 ;;^UTILITY(U,$J,358.3,32392,0)
- +354 ;;=C15.9^^99^1338^5
- +355 ;;^UTILITY(U,$J,358.3,32392,1,0)
- +356 ;;=^358.31IA^4^2
- +357 ;;^UTILITY(U,$J,358.3,32392,1,3,0)
- +358 ;;=3^Malignant neoplasm of esophagus, unspecified
- +359 ;;^UTILITY(U,$J,358.3,32392,1,4,0)
- +360 ;;=4^C15.9
- +361 ;;^UTILITY(U,$J,358.3,32392,2)
- +362 ;;=^5000919
- +363 ;;^UTILITY(U,$J,358.3,32393,0)
- +364 ;;=C32.9^^99^1338^6
- +365 ;;^UTILITY(U,$J,358.3,32393,1,0)
- +366 ;;=^358.31IA^4^2
- +367 ;;^UTILITY(U,$J,358.3,32393,1,3,0)
- +368 ;;=3^Malignant neoplasm of larynx, unspecified
- +369 ;;^UTILITY(U,$J,358.3,32393,1,4,0)
- +370 ;;=4^C32.9
- +371 ;;^UTILITY(U,$J,358.3,32393,2)
- +372 ;;=^5000956
- +373 ;;^UTILITY(U,$J,358.3,32394,0)
- +374 ;;=C34.92^^99^1338^7
- +375 ;;^UTILITY(U,$J,358.3,32394,1,0)
- +376 ;;=^358.31IA^4^2
- +377 ;;^UTILITY(U,$J,358.3,32394,1,3,0)
- +378 ;;=3^Malignant neoplasm of left bronchus/lung,unspec part
- +379 ;;^UTILITY(U,$J,358.3,32394,1,4,0)
- +380 ;;=4^C34.92
- +381 ;;^UTILITY(U,$J,358.3,32394,2)
- +382 ;;=^5000968
- +383 ;;^UTILITY(U,$J,358.3,32395,0)
- +384 ;;=C50.912^^99^1338^8
- +385 ;;^UTILITY(U,$J,358.3,32395,1,0)
- +386 ;;=^358.31IA^4^2
- +387 ;;^UTILITY(U,$J,358.3,32395,1,3,0)
- +388 ;;=3^Malignant neoplasm of left female breast,unspec site
- +389 ;;^UTILITY(U,$J,358.3,32395,1,4,0)
- +390 ;;=4^C50.912
- +391 ;;^UTILITY(U,$J,358.3,32395,2)
- +392 ;;=^5001196
- +393 ;;^UTILITY(U,$J,358.3,32396,0)
- +394 ;;=C64.2^^99^1338^9
- +395 ;;^UTILITY(U,$J,358.3,32396,1,0)
- +396 ;;=^358.31IA^4^2
- +397 ;;^UTILITY(U,$J,358.3,32396,1,3,0)
- +398 ;;=3^Malignant neoplasm of left kidney, except renal pelvis
- +399 ;;^UTILITY(U,$J,358.3,32396,1,4,0)
- +400 ;;=4^C64.2
- +401 ;;^UTILITY(U,$J,358.3,32396,2)
- +402 ;;=^5001249
- +403 ;;^UTILITY(U,$J,358.3,32397,0)
- +404 ;;=C61.^^99^1338^10
- +405 ;;^UTILITY(U,$J,358.3,32397,1,0)
- +406 ;;=^358.31IA^4^2
- +407 ;;^UTILITY(U,$J,358.3,32397,1,3,0)
- +408 ;;=3^Malignant neoplasm of prostate
- +409 ;;^UTILITY(U,$J,358.3,32397,1,4,0)
- +410 ;;=4^C61.
- +411 ;;^UTILITY(U,$J,358.3,32397,2)
- +412 ;;=^267239
- +413 ;;^UTILITY(U,$J,358.3,32398,0)
- +414 ;;=C34.91^^99^1338^11
- +415 ;;^UTILITY(U,$J,358.3,32398,1,0)
- +416 ;;=^358.31IA^4^2
- +417 ;;^UTILITY(U,$J,358.3,32398,1,3,0)
- +418 ;;=3^Malignant neoplasm of right bronchus/lung,unspec part
- +419 ;;^UTILITY(U,$J,358.3,32398,1,4,0)
- +420 ;;=4^C34.91
- +421 ;;^UTILITY(U,$J,358.3,32398,2)
- +422 ;;=^5000967
- +423 ;;^UTILITY(U,$J,358.3,32399,0)
- +424 ;;=C50.911^^99^1338^12
- +425 ;;^UTILITY(U,$J,358.3,32399,1,0)
- +426 ;;=^358.31IA^4^2
- +427 ;;^UTILITY(U,$J,358.3,32399,1,3,0)
- +428 ;;=3^Malignant neoplasm of right female breast,unspec site
- +429 ;;^UTILITY(U,$J,358.3,32399,1,4,0)
- +430 ;;=4^C50.911
- +431 ;;^UTILITY(U,$J,358.3,32399,2)
- +432 ;;=^5001195
- +433 ;;^UTILITY(U,$J,358.3,32400,0)
- +434 ;;=C64.1^^99^1338^13
- +435 ;;^UTILITY(U,$J,358.3,32400,1,0)
- +436 ;;=^358.31IA^4^2
- +437 ;;^UTILITY(U,$J,358.3,32400,1,3,0)
- +438 ;;=3^Malignant neoplasm of right kidney, except renal pelvis
- +439 ;;^UTILITY(U,$J,358.3,32400,1,4,0)
- +440 ;;=4^C64.1
- +441 ;;^UTILITY(U,$J,358.3,32400,2)
- +442 ;;=^5001248
- +443 ;;^UTILITY(U,$J,358.3,32401,0)
- +444 ;;=C44.99^^99^1338^14
- +445 ;;^UTILITY(U,$J,358.3,32401,1,0)
- +446 ;;=^358.31IA^4^2
- +447 ;;^UTILITY(U,$J,358.3,32401,1,3,0)
- +448 ;;=3^Malignant neoplasm of skin,Oth Spec
- +449 ;;^UTILITY(U,$J,358.3,32401,1,4,0)
- +450 ;;=4^C44.99
- +451 ;;^UTILITY(U,$J,358.3,32401,2)
- +452 ;;=^5001094
- +453 ;;^UTILITY(U,$J,358.3,32402,0)
- +454 ;;=C79.51^^99^1338^15
- +455 ;;^UTILITY(U,$J,358.3,32402,1,0)
- +456 ;;=^358.31IA^4^2
- +457 ;;^UTILITY(U,$J,358.3,32402,1,3,0)
- +458 ;;=3^Secondary malignant neoplasm of bone
- +459 ;;^UTILITY(U,$J,358.3,32402,1,4,0)
- +460 ;;=4^C79.51
- +461 ;;^UTILITY(U,$J,358.3,32402,2)
- +462 ;;=^5001350
- +463 ;;^UTILITY(U,$J,358.3,32403,0)
- +464 ;;=C79.52^^99^1338^16
- +465 ;;^UTILITY(U,$J,358.3,32403,1,0)
- +466 ;;=^358.31IA^4^2
- +467 ;;^UTILITY(U,$J,358.3,32403,1,3,0)
- +468 ;;=3^Secondary malignant neoplasm of bone marrow
- +469 ;;^UTILITY(U,$J,358.3,32403,1,4,0)
- +470 ;;=4^C79.52
- +471 ;;^UTILITY(U,$J,358.3,32403,2)
- +472 ;;=^5001351
- +473 ;;^UTILITY(U,$J,358.3,32404,0)
- +474 ;;=D47.4^^99^1339^29
- +475 ;;^UTILITY(U,$J,358.3,32404,1,0)
- +476 ;;=^358.31IA^4^2
- +477 ;;^UTILITY(U,$J,358.3,32404,1,3,0)
- +478 ;;=3^Osteomyelofibrosis
- +479 ;;^UTILITY(U,$J,358.3,32404,1,4,0)
- +480 ;;=4^D47.4
- +481 ;;^UTILITY(U,$J,358.3,32404,2)
- +482 ;;=^5002259
- +483 ;;^UTILITY(U,$J,358.3,32405,0)
- +484 ;;=D50.9^^99^1339^1
- +485 ;;^UTILITY(U,$J,358.3,32405,1,0)
- +486 ;;=^358.31IA^4^2
- +487 ;;^UTILITY(U,$J,358.3,32405,1,3,0)
- +488 ;;=3^Anemia, iron deficiency
- +489 ;;^UTILITY(U,$J,358.3,32405,1,4,0)
- +490 ;;=4^D50.9
- +491 ;;^UTILITY(U,$J,358.3,32405,2)
- +492 ;;=^5002283
- +493 ;;^UTILITY(U,$J,358.3,32406,0)
- +494 ;;=D64.9^^99^1339^2
- +495 ;;^UTILITY(U,$J,358.3,32406,1,0)
- +496 ;;=^358.31IA^4^2
- +497 ;;^UTILITY(U,$J,358.3,32406,1,3,0)
- +498 ;;=3^Anemia, unspecified
- +499 ;;^UTILITY(U,$J,358.3,32406,1,4,0)
- +500 ;;=4^D64.9
- +501 ;;^UTILITY(U,$J,358.3,32406,2)
- +502 ;;=^5002351
- +503 ;;^UTILITY(U,$J,358.3,32407,0)
- +504 ;;=D75.89^^99^1339^3
- +505 ;;^UTILITY(U,$J,358.3,32407,1,0)
- +506 ;;=^358.31IA^4^2
- +507 ;;^UTILITY(U,$J,358.3,32407,1,3,0)
- +508 ;;=3^Blood & blood forming organ disease, oth spec
- +509 ;;^UTILITY(U,$J,358.3,32407,1,4,0)
- +510 ;;=4^D75.89
- +511 ;;^UTILITY(U,$J,358.3,32407,2)
- +512 ;;=^5002392
- +513 ;;^UTILITY(U,$J,358.3,32408,0)
- +514 ;;=D89.2^^99^1339^16
- +515 ;;^UTILITY(U,$J,358.3,32408,1,0)
- +516 ;;=^358.31IA^4^2
- +517 ;;^UTILITY(U,$J,358.3,32408,1,3,0)
- +518 ;;=3^Hypergammaglobulinemia, unspecified
- +519 ;;^UTILITY(U,$J,358.3,32408,1,4,0)
- +520 ;;=4^D89.2
- +521 ;;^UTILITY(U,$J,358.3,32408,2)
- +522 ;;=^5002455
- +523 ;;^UTILITY(U,$J,358.3,32409,0)
- +524 ;;=E03.9^^99^1339^24
- +525 ;;^UTILITY(U,$J,358.3,32409,1,0)
- +526 ;;=^358.31IA^4^2
- +527 ;;^UTILITY(U,$J,358.3,32409,1,3,0)
- +528 ;;=3^Hypothyroidism, unspecified
- +529 ;;^UTILITY(U,$J,358.3,32409,1,4,0)
- +530 ;;=4^E03.9
- +531 ;;^UTILITY(U,$J,358.3,32409,2)
- +532 ;;=^5002476
- +533 ;;^UTILITY(U,$J,358.3,32410,0)
- +534 ;;=E05.90^^99^1339^30
- +535 ;;^UTILITY(U,$J,358.3,32410,1,0)
- +536 ;;=^358.31IA^4^2
- +537 ;;^UTILITY(U,$J,358.3,32410,1,3,0)
- +538 ;;=3^Thyrotoxicosis w/o thyrotoxic crisis/storm
- +539 ;;^UTILITY(U,$J,358.3,32410,1,4,0)
- +540 ;;=4^E05.90
- +541 ;;^UTILITY(U,$J,358.3,32410,2)
- +542 ;;=^5002492
- +543 ;;^UTILITY(U,$J,358.3,32411,0)
- +544 ;;=E08.42^^99^1339^10
- +545 ;;^UTILITY(U,$J,358.3,32411,1,0)
- +546 ;;=^358.31IA^4^2
- +547 ;;^UTILITY(U,$J,358.3,32411,1,3,0)
- +548 ;;=3^DM d/t underlying condition w/ diabetic polyneuropathy
- +549 ;;^UTILITY(U,$J,358.3,32411,1,4,0)
- +550 ;;=4^E08.42
- +551 ;;^UTILITY(U,$J,358.3,32411,2)
- +552 ;;=^5002524
- +553 ;;^UTILITY(U,$J,358.3,32412,0)
- +554 ;;=E09.42^^99^1339^11
- +555 ;;^UTILITY(U,$J,358.3,32412,1,0)
- +556 ;;=^358.31IA^4^2
- +557 ;;^UTILITY(U,$J,358.3,32412,1,3,0)
- +558 ;;=3^DM drug-induced w/ neurological compl w/ diabetic polyneuropathy
- +559 ;;^UTILITY(U,$J,358.3,32412,1,4,0)
- +560 ;;=4^E09.42
- +561 ;;^UTILITY(U,$J,358.3,32412,2)
- +562 ;;=^5002566
- +563 ;;^UTILITY(U,$J,358.3,32413,0)
- +564 ;;=E10.42^^99^1339^4
- +565 ;;^UTILITY(U,$J,358.3,32413,1,0)
- +566 ;;=^358.31IA^4^2
- +567 ;;^UTILITY(U,$J,358.3,32413,1,3,0)
- +568 ;;=3^DM Type 1 w/ diabetic polyneuropathy
- +569 ;;^UTILITY(U,$J,358.3,32413,1,4,0)
- +570 ;;=4^E10.42
- +571 ;;^UTILITY(U,$J,358.3,32413,2)
- +572 ;;=^5002606
- +573 ;;^UTILITY(U,$J,358.3,32414,0)
- +574 ;;=E10.65^^99^1339^5
- +575 ;;^UTILITY(U,$J,358.3,32414,1,0)
- +576 ;;=^358.31IA^4^2
- +577 ;;^UTILITY(U,$J,358.3,32414,1,3,0)
- +578 ;;=3^DM Type 1 w/ hyperglycemia
- +579 ;;^UTILITY(U,$J,358.3,32414,1,4,0)
- +580 ;;=4^E10.65
- +581 ;;^UTILITY(U,$J,358.3,32414,2)
- +582 ;;=^5002623
- +583 ;;^UTILITY(U,$J,358.3,32415,0)
- +584 ;;=E10.9^^99^1339^6
- +585 ;;^UTILITY(U,$J,358.3,32415,1,0)
- +586 ;;=^358.31IA^4^2
- +587 ;;^UTILITY(U,$J,358.3,32415,1,3,0)
- +588 ;;=3^DM Type 1 w/o complications
- +589 ;;^UTILITY(U,$J,358.3,32415,1,4,0)
- +590 ;;=4^E10.9
- +591 ;;^UTILITY(U,$J,358.3,32415,2)
- +592 ;;=^5002626
- +593 ;;^UTILITY(U,$J,358.3,32416,0)
- +594 ;;=E11.42^^99^1339^7
- +595 ;;^UTILITY(U,$J,358.3,32416,1,0)
- +596 ;;=^358.31IA^4^2
- +597 ;;^UTILITY(U,$J,358.3,32416,1,3,0)
- +598 ;;=3^DM Type 2 w/ diabetic polyneuropathy
- +599 ;;^UTILITY(U,$J,358.3,32416,1,4,0)
- +600 ;;=4^E11.42
- +601 ;;^UTILITY(U,$J,358.3,32416,2)
- +602 ;;=^5002646
- +603 ;;^UTILITY(U,$J,358.3,32417,0)
- +604 ;;=E11.65^^99^1339^8
- +605 ;;^UTILITY(U,$J,358.3,32417,1,0)
- +606 ;;=^358.31IA^4^2
- +607 ;;^UTILITY(U,$J,358.3,32417,1,3,0)
- +608 ;;=3^DM Type 2 w/ hyperglycemia
- +609 ;;^UTILITY(U,$J,358.3,32417,1,4,0)
- +610 ;;=4^E11.65
- +611 ;;^UTILITY(U,$J,358.3,32417,2)
- +612 ;;=^5002663
- +613 ;;^UTILITY(U,$J,358.3,32418,0)
- +614 ;;=E11.9^^99^1339^9
- +615 ;;^UTILITY(U,$J,358.3,32418,1,0)
- +616 ;;=^358.31IA^4^2
- +617 ;;^UTILITY(U,$J,358.3,32418,1,3,0)
- +618 ;;=3^DM Type 2 w/o complications
- +619 ;;^UTILITY(U,$J,358.3,32418,1,4,0)
- +620 ;;=4^E11.9
- +621 ;;^UTILITY(U,$J,358.3,32418,2)
- +622 ;;=^5002666
- +623 ;;^UTILITY(U,$J,358.3,32419,0)
- +624 ;;=E13.42^^99^1339^12
- +625 ;;^UTILITY(U,$J,358.3,32419,1,0)
- +626 ;;=^358.31IA^4^2
- +627 ;;^UTILITY(U,$J,358.3,32419,1,3,0)
- +628 ;;=3^DM oth w/ diabetic polyneuropathy
- +629 ;;^UTILITY(U,$J,358.3,32419,1,4,0)
- +630 ;;=4^E13.42
- +631 ;;^UTILITY(U,$J,358.3,32419,2)
- +632 ;;=^5002686
- +633 ;;^UTILITY(U,$J,358.3,32420,0)
- +634 ;;=E16.2^^99^1339^22
- +635 ;;^UTILITY(U,$J,358.3,32420,1,0)
- +636 ;;=^358.31IA^4^2
- +637 ;;^UTILITY(U,$J,358.3,32420,1,3,0)
- +638 ;;=3^Hypoglycemia, unspecified
- +639 ;;^UTILITY(U,$J,358.3,32420,1,4,0)
- +640 ;;=4^E16.2
- +641 ;;^UTILITY(U,$J,358.3,32420,2)
- +642 ;;=^5002708
- +643 ;;^UTILITY(U,$J,358.3,32421,0)
- +644 ;;=E46.^^99^1339^26
- +645 ;;^UTILITY(U,$J,358.3,32421,1,0)
- +646 ;;=^358.31IA^4^2
- +647 ;;^UTILITY(U,$J,358.3,32421,1,3,0)
- +648 ;;=3^Malnutrition, protein-calorie, unspec
- +649 ;;^UTILITY(U,$J,358.3,32421,1,4,0)
- +650 ;;=4^E46.
- +651 ;;^UTILITY(U,$J,358.3,32421,2)
- +652 ;;=^5002790
- +653 ;;^UTILITY(U,$J,358.3,32422,0)
- +654 ;;=E53.8^^99^1339^31
- +655 ;;^UTILITY(U,$J,358.3,32422,1,0)
- +656 ;;=^358.31IA^4^2
- +657 ;;^UTILITY(U,$J,358.3,32422,1,3,0)
- +658 ;;=3^Vitamin B group deficiency
- +659 ;;^UTILITY(U,$J,358.3,32422,1,4,0)
- +660 ;;=4^E53.8
- +661 ;;^UTILITY(U,$J,358.3,32422,2)
- +662 ;;=^5002797
- +663 ;;^UTILITY(U,$J,358.3,32423,0)
- +664 ;;=E66.01^^99^1339^27
- +665 ;;^UTILITY(U,$J,358.3,32423,1,0)
- +666 ;;=^358.31IA^4^2
- +667 ;;^UTILITY(U,$J,358.3,32423,1,3,0)
- +668 ;;=3^Obesity, morbid
- +669 ;;^UTILITY(U,$J,358.3,32423,1,4,0)
- +670 ;;=4^E66.01
- +671 ;;^UTILITY(U,$J,358.3,32423,2)
- +672 ;;=^5002826
- +673 ;;^UTILITY(U,$J,358.3,32424,0)
- +674 ;;=E66.9^^99^1339^28
- +675 ;;^UTILITY(U,$J,358.3,32424,1,0)
- +676 ;;=^358.31IA^4^2
- +677 ;;^UTILITY(U,$J,358.3,32424,1,3,0)
- +678 ;;=3^Obesity, unspecified
- +679 ;;^UTILITY(U,$J,358.3,32424,1,4,0)
- +680 ;;=4^E66.9
- +681 ;;^UTILITY(U,$J,358.3,32424,2)
- +682 ;;=^5002832
- +683 ;;^UTILITY(U,$J,358.3,32425,0)
- +684 ;;=E74.39^^99^1339^25
- +685 ;;^UTILITY(U,$J,358.3,32425,1,0)
- +686 ;;=^358.31IA^4^2
- +687 ;;^UTILITY(U,$J,358.3,32425,1,3,0)
- +688 ;;=3^Intestinal carbohydrate absorption disorder, other